Through its partnership with MGC Pharmaceuticals, Inc., AMC Holdings will focus on the following products on the positioning for which U.S. trials are in process.
Supporting Scientists, Clinicians and Patients
We are supplying plant-inspired medication “phytomedicine” and novel product candidates for adults and children.
We use our deep knowledge in these fields to innovate and identify new solutions where none previously existed to improve people's lives.
We are investigating and delivering medicines for
Epilepsy
is a central nervous system disorder in which brain activity becomes abnormal, causing seizures
Dementia
is the loss of cognitive functioning. That it interferes with a person's daily life
Covid-19
is an infectious disease caused by the SARS-CoV-2 virus
Cancer
is a group of diseases involving abnormal cell growth
Crohn’s
is an inflammatory bowel disease that causes chronic inflammation of the gastrointestinal tract
About Us
AMC Holdings arranges for leading U.S. researchers, academic institutions and physicians to join existing clinical trials performed by leading biotech and pharmaceutical manufacturers abroad.